NEWS
BIOLYTICA TURNS TO PRESIDIO TO UNLOCK THE POWER OF HEALTH DATA
Biolytica has turned to Presido , a leading global digital services and solution provider , to develop an innovative platform to support longevity and data-driven health optimisation for healthcare professionals .
Presidio cloud engineers and software developers worked with Biolytica to architect and deliver a leading-edge international healthcare solution that harnesses the power of data and advanced analytics to create and maintain personalised health optimisation and longevity plans .
“ The science of longevity is not just about living longer , it ’ s about living healthier , longer ,” said Dan Fobes , Co-Founder and VP of Engineering at Biolytica . “ While many books and articles on longevity provide general direction , what ’ s needed is a personalised software solution that incorporates an individual ’ s genetics , biomarkers and lifestyle choices that produce measurable results . Bringing this information together enables effective planning for longevity and is important in areas of prevention , chronic disease management and telehealth . Presidio
has been a true partner in realising our vision , helping us architect and implement a secure solution that has enabled clinicians worldwide to create effective health optimisation plans personalised to each of their clients .”
Biolytica and Presidio collaborated to create NEXUS . The platform provides clinicians with the ability to visualise , correlate and analyse health-related data , which enables them to identify opportunities to increase health span – the part of a person ’ s life during which they are generally in good health .
SEQERA LABS AND GENOMICS ENGLAND ENHANCE GENOMIC RESEARCH CAPABILITIES
Seqera Labs , a leading provider of secure workflow orchestration software in the life sciences sector , has partnered with Genomics England . The new collaboration between Seqera Labs and Genomics England will enable whole genome analysis to be carried out at a larger scale with greater efficiency , helping more patients benefit from genomic healthcare and equipping researchers with extra data to find the causes of disease and develop new treatments . and cancer . The data collected by Genomics England is stored in the National Genomic Research Library and can be accessed by approved researchers via a secure research environment enabling them to deliver ground-breaking insights into both therapeutics and diagnostics , and has been used by scientists to propose updated global guidelines to improve rare disease diagnosis . will deploy Seqera Labs ’ Nextflow Tower – an intuitive , centralised command post that enables largescale collaborative data analysis .
With Tower , Genomics England will be able to quickly launch , manage and monitor scalable data analysis pipelines within the cloud .
Building on the UK ’ s reputation as a global leader in life sciences , Genomics England is working with the NHS to deliver whole genome sequencing as part of the NHS Genomic Medicine Service for patients with rare diseases
The partnership with Seqera Labs will scale Genomics England ’ s capacity to develop models for disease diagnosis , prognosis and treatment response . Genomics England
www . intelligenthealth . tech 7